GGrantIndex
← Search

An immunodominance-based Pan-Pneumovirus vaccine for protection against RSV and hMPV

$629,209R01FY2023AINIH

Florida State University, Tallahassee FL

Investigators

Linked publications & trials

View original record on NIH RePORTER →